HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IOA Anticaries Test Alternative To Be Reviewed By FDA Advisory Committee

This article was originally published in The Rose Sheet

Executive Summary

An FDA advisory committee will explore whether or not the Intraoral Appliance (IOA) model should be permitted in place of animal caries studies currently required in the OTC anticaries monograph, FDA says in a 1March 15 Federal Register notice

You may also be interested in...



Anticaries Alternative Test Review Should Include Multiple Methods – CTFA

FDA should evaluate multiple alternative test methods in addition to the Intraoral Appliance (IOA) model as it considers non-animal test methods for OTC anticaries products, the Cosmetic, Toiletry and Fragrance Association and Consumer Healthcare Products Association Joint Anticaries Task Group says

Anticaries Alternative Test Review Should Include Multiple Methods – CTFA

FDA should evaluate multiple alternative test methods in addition to the Intraoral Appliance (IOA) model as it considers non-animal test methods for OTC anticaries products, the Cosmetic, Toiletry and Fragrance Association and Consumer Healthcare Products Association Joint Anticaries Task Group says

IOA Data Extension Would Incorporate On-Going Research – CTFA/CHPA

FDA should extend the comment period on use of intraoral appliance models as an alternative to animal caries reduction tests by 180 days, the Consumer Healthcare Products Association and the Cosmetic, Toiletry and Fragrance Association say in a joint request filed Nov. 14

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel